Sanara MedTech Inc. (SMTI)
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Address
1200 SUMMIT AVE
FORT WORTH, TX 76102
Founded
1982
Number of Employees
107
Website
http://www.sanaramedtech.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | - | $346 | - | - | $346 |
| Average Price | - | - | - | - | - | - | - | - | $29.49 | - | - | $29.49 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 11,745 | - | - | 11,745 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | 15.3% | - | - | 15.3% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | - | - | 37.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | -22.0% | - | - | -22.0% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 60% | - | - | 52% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at SMTI make a trade.
Creating a free account takes less than one minute